Gene Expression Regulation, Neoplastic
"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
| Descriptor ID |
D015972
|
| MeSH Number(s) |
G05.308.370
|
| Concept/Terms |
Gene Expression Regulation, Neoplastic- Gene Expression Regulation, Neoplastic
- Regulation of Gene Expression, Neoplastic
- Regulation, Gene Expression, Neoplastic
- Neoplastic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".
This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 2 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 5 | 6 |
| 2004 | 0 | 6 | 6 |
| 2005 | 2 | 6 | 8 |
| 2006 | 0 | 3 | 3 |
| 2007 | 3 | 4 | 7 |
| 2008 | 8 | 7 | 15 |
| 2009 | 4 | 8 | 12 |
| 2010 | 3 | 6 | 9 |
| 2011 | 5 | 9 | 14 |
| 2012 | 8 | 6 | 14 |
| 2013 | 5 | 13 | 18 |
| 2014 | 5 | 7 | 12 |
| 2015 | 7 | 10 | 17 |
| 2016 | 6 | 17 | 23 |
| 2017 | 9 | 14 | 23 |
| 2018 | 6 | 12 | 18 |
| 2019 | 5 | 8 | 13 |
| 2020 | 5 | 14 | 19 |
| 2021 | 5 | 9 | 14 |
| 2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.
-
ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma. World J Pediatr. 2022 04; 18(4):285-293.
-
Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent. Biotech Histochem. 2022 Jan; 97(1):1-10.
-
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival. Theranostics. 2022; 12(2):639-656.
-
Drug delivery approaches for HuR-targeted therapy for lung cancer. Adv Drug Deliv Rev. 2022 01; 180:114068.
-
The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis. Mol Cancer. 2021 11 10; 20(1):145.
-
Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin. mSphere. 2021 10 27; 6(5):e0075121.
-
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Sci Rep. 2021 09 09; 11(1):18009.
-
GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules. 2021 08 14; 11(8).
-
Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells. FEBS J. 2021 12; 288(23):6683-6699.
-
WNK1 Enhances Migration and Invasion in Breast Cancer Models. Mol Cancer Ther. 2021 10; 20(10):1800-1808.